Immunotherapy of HIV-infected Patients: A Single-blinded, Randomized, Immunogenicity, Pilot Study of Intranasal Administration of Vacc-4x With Endocine as Adjuvant
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Vacc-4x (Primary) ; Endocine
- Indications HIV infections
- Focus Adverse reactions
- 29 Jan 2018 According to a Bionor media release, Bionor Pharma changed its name to Bionor Holding.
- 19 Jun 2012 Actual end date Mar 2012 added as reported by ClinicalTrials.gov.
- 19 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.